☆ 4.8 Article

Inhaled pulmonary surfactant biomimetic liposomes for reversing idiopathic pulmonary fibrosis through synergistic therapeutic strategy

BIOMATERIALS (2023)

Related references

Note: Only part of the references are listed.

Article Pediatrics

European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update

David G. Sweet et al.

Summary: The sixth version of European Guidelines for the Management of RDS has been developed by a panel of experienced European neonatologists and an expert perinatal obstetrician based on available literature up to end of 2022. These updated guidelines aim to optimize outcomes for babies with RDS through various measures such as prediction of risk of preterm delivery, appropriate maternal transfer to a perinatal center, and evidence-based lung-protective management. The guidelines also address the importance of general care for infants with RDS, including cardiovascular support and judicious use of antibiotics. The guidelines have received endorsement from the European Society for Paediatric Research (ESPR) and the Union of European Neonatal and Perinatal Societies (UENPS). Rating: 7 out of 10.

NEONATOLOGY (2023)

Add to Collection

Review Chemistry, Multidisciplinary

Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges

Popat Kumbhar et al.

Summary: This paper discusses the feasibility of releasing repurposed non-oncology drugs (RNODs) through inhalation, explores their application in treating lung cancer (LC) and related challenges, as well as the role of nanocarriers (NCs) in improving lung deposition and targeting.

JOURNAL OF CONTROLLED RELEASE (2022)

Add to Collection

Review Pharmacology & Pharmacy

Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis

Cristina Estornut et al.

Summary: This review discusses the role of oxidative stress in the development and progression of IPF, the underlying mechanisms, and the evidence of oxidative stress in human IPF. It also analyzes the mechanism of action, efficacy, and current status of different drugs developed to inhibit oxidative stress as anti-fibrotic therapy in IPF.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Nanoparticle-Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis

Qiutong Jin et al.

Summary: This study developed an inhaled immunotherapeutic chitosan-antibody complex that effectively activates the immune system, promotes infiltration of different immune cells around tumor lesions, and prolongs the survival of mice.

ADVANCED MATERIALS (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges

Ling Ding et al.

Summary: Lung diseases are a major cause of mortality worldwide, with an urgent need for new therapies. The approval of siRNA treatments in humans has opened up possibilities for exploring this therapeutic strategy further across different disease states. Advancements in pulmonary delivery of siRNA-based biopharmaceuticals offer promise in addressing unmet medical needs, but the complexity of efficient delivery remains a challenge. Current research focuses on understanding barriers to pulmonary siRNA delivery and recent successful developments in this field.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection

Review Medicine, General & Internal

Pharmacological treatment of idiopathic pulmonary fibrosis and fibrosing interstitial lung diseases: current trends and future directions

Won-Il Choi

Summary: Idiopathic pulmonary fibrosis (IPF) was previously considered untreatable, but with the development of therapeutic drugs such as pirfenidone and nintedanib, it is now possible to slow the progression of the disease. These drugs have proven effective in reducing pulmonary fibrosis, acute exacerbation, and mortality, regardless of the severity of IPF. The future of IPF management may involve combinations of therapies targeting a range of disease mechanisms.

PRECISION AND FUTURE MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis

Phuong-Uyen C. Dinh et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis

Tanyalak Parimon et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Multidisciplinary Sciences

Monocyte-derived multipotent cell delivered programmed therapeutics to reverse idiopathic pulmonary fibrosis

Xin Chang et al.

SCIENCE ADVANCES (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Mediated Drug Release from Nanovehicles by Black Phosphorus Quantum Dots for Efficient Therapy of Chronic Obstructive Pulmonary Disease

Zhibin Li et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Add to Collection

Review Respiratory System

The Future of Pharmacological Treatment in Idiopathic Pulmonary Fibrosis

Maria Molina-Molina

ARCHIVOS DE BRONCONEUMOLOGIA (2019)

Add to Collection

Article Critical Care Medicine

Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study

Ganesh Raghu et al.

LANCET RESPIRATORY MEDICINE (2019)

Add to Collection

Article Multidisciplinary Sciences

An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases

Yang Liu et al.

NATURE COMMUNICATIONS (2019)

Add to Collection

Article Critical Care Medicine

Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Add to Collection

Review Medicine, General & Internal

Idiopathic Pulmonary Fibrosis (IPF): An Overview

Shaney L. Barratt et al.

JOURNAL OF CLINICAL MEDICINE (2018)

Add to Collection

Review Cell Biology

The micromechanics of lung alveoli: structure and function of surfactant and tissue components

Lars Knudsen et al.

HISTOCHEMISTRY AND CELL BIOLOGY (2018)

Add to Collection

Article Chemistry, Multidisciplinary

Pulmonary surfactant and drug delivery: Focusing on the role of surfactant proteins

Roberta Guagliardo et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Add to Collection

Correction Biotechnology & Applied Microbiology

Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease (vol 16, pg 755, 2017)

Ana L. Mora et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Add to Collection

Article Anatomy & Morphology

Pulmonary surfactant metabolism in the alveolar airspace: Biogenesis, extracellular conversions, recycling

Barbara Olmeda et al.

ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2017)

Add to Collection

Article Pediatrics

A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome

David G. Sweet et al.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films

Elisa Parra et al.

CHEMISTRY AND PHYSICS OF LIPIDS (2015)

Add to Collection

Article Pharmacology & Pharmacy

Barrier or carrier? Pulmonary surfactant and drug delivery

Alberto Hidalgo et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)

Add to Collection

Article Chemistry, Multidisciplinary

Bio-inspired pulmonary surfactant-modified nanogels: A promising siRNA delivery system

Lynn De Backer et al.

JOURNAL OF CONTROLLED RELEASE (2015)

Add to Collection

Article Medicine, General & Internal

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection

Article Medicine, Research & Experimental

Type 2 alveolar cells are stem cells in adult lung

Christina E. Barkauskas et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Add to Collection

Review Medicine, Research & Experimental

Alveolar Surfactant Homeostasis and the Pathogenesis of Pulmonary Disease

Jeffrey A. Whitsett et al.

ANNUAL REVIEW OF MEDICINE (2010)

Add to Collection

Article Biophysics

Segregated Phases in Pulmonary Surfactant Membranes Do Not Show Coexistence of Lipid Populations with Differentiated Dynamic Properties

Jorge Bernardino de la Serna et al.

BIOPHYSICAL JOURNAL (2009)

Add to Collection

Review Biotechnology & Applied Microbiology

Inhaling medicines: delivering drugs to the body through the lungs

John S. Patton et al.

NATURE REVIEWS DRUG DISCOVERY (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.